HOME >> MEDICINE >> NEWS
UCLA Nobel Laureate honored with membership in the American Philosophical Society

Louis J. Ignarro, Ph.D. (Beverly Hills, Calif.), distinguished professor of pharmacology at the David Geffen School of Medicine at UCLA and winner of the 1998 Nobel Prize in medicine, has been elected to the American Philosophical Society.

Founded in 1743 by Benjamin Franklin, the American Philosophical Society is the countrys oldest learned society, recognizing extraordinary achievements in science, letters and the arts. Ignarro joins an illustrious group of members that has included Charles Darwin, Marie Curie, Albert Einstein, Andrew Carnegie and Beverly Sills.

The American Philosophical Society promotes knowledge through scholarly research, professional meetings, publications, library resources and community outreach. Currently, there are 900 members.

Ignarros groundbreaking discovery of the importance of nitric oxide in cardiovascular health secured him the 1998 Nobel Prize. He found that nitric oxide is produced in the blood vessels and controls the flow of blood by signaling vessels to expand and contract. A shortage in nitric oxide production, caused by poor diet and lack of physical activity, can lead to cardiovascular disease including heart attack, stroke and high cholesterol.

Ignarro also discovered that nitric oxide is the neurotransmitter responsible for penile erection, which led to the development of Viagra, the first oral medication for the treatment of erectile dysfunction.

Additional prestigious awards Ignarro has received include the Basic Research Prize of the American Heart Association, the CIBA Award for Hypertension Research and the Roussel Uclaf Prize for Cell Communication and Signaling. He has been elected to the National Academy of Sciences and the American Academy of Arts and Sciences and has published more than 500 articles. Ignarro, who has been at UCLA for 22 years, is currently a professor of molecular and medical pharmacology at the David Geffen School of Medicine
'"/>

Contact: Rachel Champeau
rchampeau@mednet.ucla.edu
310-794-0777
University of California - Los Angeles
18-May-2007


Page: 1 2

Related medicine news :

1. New research says winning a Nobel Prize adds nearly two years to your lifespan
2. Nobel Laureate keynote speaker at conference on nanomedicine, geriatric care, brain injury
3. Nobel Laureates featured in symposium in honor of new research center at NYU School of Medicine
4. Nobel Laureate Eric Kandel condemns censorship of scientists
5. Nobel Laureate Eric Kandel to discuss the New Science of the Mind
6. Researchers win Nobel Medicine Prize for discovering cause of ulcers
7. Heroes of Chemistry honored for medical, energy, environmental breakthroughs
8. UCLA pediatrician honored with prestigious achievement award
9. UQ researchers honored with leading fellowships
10. U of M faculty honored by US FDA for contributions to national food safety and defense
11. UCLA surgeon honored with American Association for Thoracic Surgerys Achievement Award

Post Your Comments:
(Date:9/2/2015)... ... September 02, 2015 , ... Healthegy, ... announced the two leaders who will deliver keynote presentations at the upcoming Digital ... Mandarin Oriental Hotel in Boston. , Larry Renfro, CEO of Optum, will deliver ...
(Date:9/2/2015)... ... September 02, 2015 , ... Based in Beverly Hills, Luxury ... truly superb luxury vehicles based on which of the latest and greatest vehicles their ... step forward in pursuit of this goal: a 2015 Rolls Royce Wraith rental ...
(Date:9/2/2015)... ... September 02, 2015 , ... The Western ... and Mildred Goldstein Charitable Trust to establish the Abraham and Mildred Goldstein Endowment ... months after WCHN recruited nationally known gynecologic oncologist Thomas J. Rutherford, MD, PhD ...
(Date:9/2/2015)... ... 2015 , ... Date and time: Oct. 3, 2015, 9 a.m. to 4 ... Road, Bryn Athyn, Pa 19009 , Cost: $50 per person; includes lunch , The ... best-selling author Sam Keen based on his new book which he co-authored with his ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... safety and efficacy endpoint data collection, cloud analytics and workflow solutions today ... The series enables pharmaceutical researchers to participate in interactive programs in which ...
Breaking Medicine News(10 mins):Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 2Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 3Health News:Luxury Line Auto Rental Announces Addition of the Rolls Royce Wraith to their Luxury Fleet 2Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 2Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 3Health News:justCommunity, Inc. and Bryn Athyn Men’s Groups Present Workshop on Family Reconciliation 2Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 2Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 3
(Date:9/2/2015)... , Sept. 2, 2015   About ELISA test ... common laboratory technologies that is used for measuring the ... solution. ELISA test uses various types of enzymes such ... the result is detected by photometry or fluorometry. ELISA ... of various infectious diseases such as HIV, pernicious anemia, ...
(Date:9/2/2015)... Sept. 2, 2015 Research and Markets ( http://www.researchandmarkets.com/research/l8z67c/pharmaceutical ... Affairs in China (Basel, Switzerland - November 26-27, 2015)" ... provide a detailed overview of the key areas of pharmaceutical ... Hong Kong , Macau and ... - All important aspects of gaining and maintaining a ...
(Date:9/2/2015)... , Sept. 2, 2015  Seeger Weiss LLP is ... trial will commence October 13, 2015. ... 510K fast-track approval program, Zimmer NexGen knee implant surpassed ... requires that companies provide evidence that the product is ... order to gain permissions. In 2001, ...
Breaking Medicine Technology:Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 2Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 3Pharmaceutical Regulatory Affairs in China Seminar: Basel, Switzerland - November 26-27, 2015 2Seeger Weiss LLP Reports That Zimmer NexGen Knee MDL Bellwether Trial Date Set For October 13, 2015 2
Cached News: